View More Recent Stories
-
Alkermes (ALKS) Shares Trade off LOD, Down ~2%, Jefferies Out With Cmnts from Mgmt Meet
-
Mizuho on Alkermes (ALKS): 'we believe these data are not sufficient to draw any definitive conclusion'
-
Alkermes (ALKS) Announces Initiation of Vibrance-2 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 2
-
Alkermes (ALKS) PT Raised to $38 at Baird
-
Alkermes (ALKS) PT Raised to $37 at H.C. Wainwright
-
Alkermes (ALKS) Tops Q2 EPS by 4c
-
TD Cowen Starts Alkermes (ALKS) at Buy
